United Therapeutics (UTHR) Debt Ratio (2010 - 2025)

United Therapeutics (UTHR) has 14 years of Debt Ratio data on file, last reported at 0.03 in Q1 2025.

• For the quarter ending Q1 2025, Debt Ratio fell 72.04% year-over-year to 0.03; the trailing twelve-month figure through Mar 2025 stood at 0.03 (down 72.04% YoY), and the FY2024 full-year result was 0.04, down 58.29% from the prior year.
• Debt Ratio eased to 0.03 in Q1 2025, from 0.04 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 153.85 in Q3 2024 to a low of 0.03 in Q1 2025.
• A 5-year average of 9.16 and a median of 0.13 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 134969.23% in 2024 and tumbled 72.04% in 2025, its largest moves.
• Tracing UTHR's Debt Ratio over 5 years: stood at 0.15 in 2021, then declined by 14.48% to 0.13 in 2022, then declined by 26.2% to 0.1 in 2023, then plunged by 58.29% to 0.04 in 2024, then slumped by 36.6% to 0.03 in 2025.
• Business Quant data shows UTHR's Debt Ratio at 0.03 in Q1 2025, 0.04 in Q4 2024, and 153.85 in Q3 2024.